RTTNews | Jan 13, 2022 04:10AM EST

04:09 Thursday, January 13, 2022 (RTTNews) - Adagene Doses First Patients With Advanced NSCLC In Phase 1b/2 Clinical Trial Of ADG106 With Nivolumab In Singapore

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved